JAMES ROONEY: Open Payments
NPI 1922053594 · SAFETY HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 17 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $689 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $141 |
| Janssen Pharmaceuticals, Inc | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| Alkermes, Inc. | 1 | $19 |
Products named: INGREZZA, CAPLYTA, INVEGA, ABILIFY ASIMTUFII, COBENFY, AUSTEDO XR, ARISTADA, UZEDY.
Industry payments across FL — which companies pay providers there.
